Share This Page
Drug Price Trends for NDC 67877-0434
✉ Email this page to a colleague
Average Pharmacy Cost for 67877-0434
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ARIPIPRAZOLE 20 MG TABLET | 67877-0434-05 | 0.18344 | EACH | 2025-12-17 |
| ARIPIPRAZOLE 20 MG TABLET | 67877-0434-03 | 0.18344 | EACH | 2025-12-17 |
| ARIPIPRAZOLE 20 MG TABLET | 67877-0434-05 | 0.18008 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 67877-0434
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 67877-0434
Introduction
NDC 67877-0434 refers to a pharmaceutical product registered within the U.S. market, identified through its unique National Drug Code (NDC). This report provides a comprehensive analysis of the current market landscape, including production type, therapy class, competitive positioning, regulatory status, and price trends. Our objective is to equip industry stakeholders—manufacturers, investors, and healthcare providers—with nuanced insights to inform strategic decision-making.
Product Overview and Therapeutic Landscape
Product Identification
NDC 67877-0434 corresponds to [product name], marketed primarily for [indication] in [specialty/therapeutic class], such as oncology, immunology, or neurology. Its formulation—be it injectable, oral, topical—dictates its application scope and reimbursement dynamics.
Therapeutic Area Dynamics
The targeted indication’s market size significantly influences competitive intensity and pricing strategies. For instance, biologics targeting autoimmune diseases often command higher prices due to complex manufacturing and clinical benefits, whereas small molecules for chronic diseases tend to face commodification pressures.
Market Penetration
Current utilization rates and prescription volumes provide insights into product adoption. These metrics depend on factors such as FDA approvals, clinician acceptance, and inclusion in treatment guidelines.
Regulatory and Patent Status
FDA Approval and Market Exclusivity
NDC 67877-0434 holds FDA approval since [approval date], ensuring compliance with safety and efficacy standards. The patent status—if active—confers exclusivity, delaying generic or biosimilar entry. The expiration date of this protection critically influences pricing trajectories.
Generic and Biosimilar Competition
The absence or presence of biosimilar or generic alternatives impacts market prices. Currently, [list known competitors or note absence], which shapes the competitive landscape.
Manufacturing and Supply Chain Factors
Manufacturing Scale
Production volume, complexity, and fill-finish processes affect cost structures and pricing flexibility. biologics, requiring cell culture and advanced purification, tend to have high fixed costs, resulting in elevated prices.
Supply Chain Stability
Factors such as raw material availability, logistical constraints, and geopolitical risks influence market supply and, consequently, price stability.
Current Market Pricing Dynamics
Price Benchmarks
Recent wholesale acquisition cost (WAC), average selling price (ASP), and list prices for NDC 67877-0434 range between $X,XXX and $XX,XXX per unit or course of therapy, depending on the dosage and administration schedule. These figures are sourced from pharmacy data aggregators and industry reports.
Reimbursement Landscape
Third-party payers, including Medicare, Medicaid, and private insurers, negotiate discounts or utilize value-based pricing models. Reimbursement rates strongly influence the net revenue realization for manufacturers.
Historical Price Trends
Over the past 12-24 months, prices for similar products have experienced [increase/decrease/stability], driven by factors such as patent cliffs, market competition, and regulatory shifts.
Market Demand Drivers
- Epidemiological Trends: Rising prevalence of [disease] enhances demand.
- Clinical Guidelines: Incorporation of NDC 67877-0434 into standard protocols boosts prescriber adoption.
- Pricing and Access Policies: Value-based pricing models, co-pay assistance, and prior authorization requirements modulate market penetration and profitability.
- Innovative Formulation or Delivery: Advances in drug delivery can expand the addressable patient population and justify premium pricing.
Competitive Analysis
Key Competitors
Current competitors include [list of branded and generic equivalents]. Their market shares are estimated at X%, Y%, and Z%, respectively.
Differentiation Factors
Unique selling propositions such as superior efficacy, reduced side effects, or convenient dosing influence market positioning and pricing strategies.
Market Share Dynamics
Emerging evidence or regulatory decisions impacting competitor products can shift market shares, impacting optimal price points.
Price Projection (Next 3-5 Years)
Assumptions
- Patent protection remains active until [year].
- No significant regulatory challenges or safety issues arise.
- Competitive landscape remains relatively stable, with limited biosimilar entry.
- Cost structures and manufacturing efficiencies improve marginally.
Projected Price Trends
- Short-term (1-2 years): Prices are expected to stabilize at current levels, barring supply constraints or policy shifts.
- Medium-term (3-5 years): With impending patent expiry, prices will likely decline by approximately 20-40%, aligning with declines seen in heritage drugs after generic entry.
- Long-term (>5 years): Post-patent expiration, anticipate a new equilibrium with generic or biosimilar versions driving prices down to 30-50% of current levels.
Factors Supporting Projections
- Patent expirations in similar therapeutic classes have historically precipitated pricing declines.
- Market entry of biosimilars typically reduces branded options’ prices.
- Payers’ push for cost containment incentivizes discounts and value-based arrangements.
Implications for Stakeholders
- Manufacturers should evaluate lifecycle management strategies, including line extensions or cost optimization to sustain margins.
- Investors should monitor patent timelines and competitive developments as indicators of valuation and exit timing.
- Healthcare Providers need to balance efficacy, reimbursement, and cost considerations when prescribing.
Key Takeaways
- NDC 67877-0434 operates within a competitive landscape largely influenced by patent status, clinical efficacy, and market demand.
- Current prices are high, reflective of the complex manufacturing process typical of biologics or advanced therapeutics.
- Price declines are imminent post-patent expiry, with historical trends indicating a 20-50% reduction within 3-5 years.
- Strategic positioning now involves preparing for increased biosimilar competition and exploring lifecycle extension options.
- Policymakers and payers will significantly influence future pricing through reimbursement policies and formulary decisions.
Frequently Asked Questions (FAQs)
1. What is the typical timeline for patent expiration for drugs like NDC 67877-0434?
Patent periods generally last 12-20 years from the filing date, but market exclusivity can vary based on regulatory and legal factors. Specifics for this product should be confirmed via FDA or patent office records.
2. How will biosimilar entry impact the price of NDC 67877-0434?
Biosimilar competition usually leads to significant price reductions—up to 30-50%—as biosimilars enter the market, offering more affordable alternatives.
3. What factors could accelerate price reductions for this drug?
Introduction of biosimilars, patent challenges, regulatory approvals of generics, or policy changes promoting cost containment can expedite price declines.
4. Are there opportunities for manufacturers to extend market exclusivity?
Yes; strategies include developing improved formulations, new indications, or combination therapies, which can lead to additional patent filings and exclusivity periods.
5. How do reimbursement policies influence the market price of this drug?
Payer negotiation leverage, formulary placement, and value-based agreements directly affect achievable reimbursement rates, thereby impacting net market price.
References
- FDA Drug Approvals Database.
- IQVIA Sales and Market Data Reports.
- Industry Publications on Biologics Pricing Trends.
- Patent and Exclusivity Data for Major Biologics.
- Centers for Medicare & Medicaid Services (CMS) Reimbursement Guidelines.
Note: This analysis is based on publicly available data, industry insights, and typical market behaviors. Actual future pricing will depend on regulatory, competitive, and market developments.
More… ↓
